DERM Journey Medical Corporation - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$6.61
· of 52w range
· above low
· to high
$4.3152w low
$9.5052w high
P/E (TTM)
-30.0
EPS (TTM)
$-0.22
Revenue (TTM)
$68M
your badges
52W Range
$4–$9
Analyst Rating
BUY
Price Target
$14
P/E
-30.0
ROE
-23.8%
Net Profit Margin
-9.0%
Your badge strip is empty — pin a metric anywhere on this page.
DERM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.61
P/E (TTM)
-30.0
EPS (TTM)
$-0.22
Revenue (TTM)
$68M
ROE (TTM)
-23.8%
Debt/Equity (MRQ)
0.8
52W Range
$4–$9
DERM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$62M2020-12-31 → 2025-12-31
EPS$-0.472020-12-31 → 2025-12-31
Free Cash Flow·2022-12-31 → 2024-12-31
Net margin-9.0%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DERM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -30.05Y avg ≈-10.3 | ≈-10.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DERM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -4.4%5Y avg ≈-26.6% | ≈-26.6% | -590.8% | Top tier | |
| EBITDA Margin | -13.2%5Y avg ≈-26.6% | ≈-26.6% | -294.2% | Top tier | |
| Pretax Margin (TTM) | -8.9%5Y avg ≈-31.2% | ≈-31.2% | 36.2% | Weak | |
| Net Profit Margin (TTM) | -9.0%5Y avg ≈-31.9% | ≈-31.9% | 14.4% | Below avg | |
| ROA (TTM) | -6.8%5Y avg ≈-24.8% | ≈-24.8% | -13.1% | In line | |
| ROE (TTM) | -23.8%5Y avg ≈-117.4% | ≈-117.4% | -33.5% | Weak | |
| ROIC | -14.4%5Y avg ≈-42.5% | ≈-42.5% | -14.4% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DERM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.85Y avg ≈1.0 | ≈1.0 | 1.1 | Low debt | |
| Current Ratio (MRQ) | 1.65Y avg ≈1.5 | ≈1.5 | 4.7 | Low liquidity | |
| Quick Ratio | 1.45Y avg ≈1.1 | ≈1.1 | 1.5 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.65Y avg ≈1.0 | ≈1.0 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | DERM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 10.2%5Y avg ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 3Y | -5.7%5Y avg ≈3.9% | ≈3.9% | · | · | |
| Revenue CAGR 5Y | 6.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | DERM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.75Y avg ≈0.8 | ≈0.8 | 0.4 | Top tier | |
| Inventory Turnover | 1.75Y avg ≈2.8 | ≈2.8 | 0.8 | Top tier | |
| Receivables Turnover | 3.15Y avg ≈3.3 | ≈3.3 | 6.1 | Weak | |
| Revenue / Employee | ≈$1.1M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
3.7%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.01 | $-0.02 | 56.3% |
| March 31, 2026 | May 13, 2026 | $-0.08 | $-0.08 | -1.1% |
| Dec. 31, 2025 | $-0.05 | $-0.06 | 21.6% | |
| Sept. 30, 2025 | $-0.09 | $-0.05 | -85.6% | |
| June 30, 2025 | $-0.16 | $-0.11 | -49.4% | |
| March 31, 2025 | $-0.18 | $-0.24 | 25.7% | |
| Dec. 31, 2024 | $-0.15 | $-0.36 | 58.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $62M | $56M | $79M | $74M | $63M | $45M | |
| Cost of Revenue | $21M | $21M | $23M | $31M | $32M | $15M | |
| R&D Expense | $480.0K | $10M | $8M | $11M | $3M | · | |
| SG&A Expense | $44M | $40M | $44M | $59M | $40M | $22M | |
| Operating Expenses | $70M | $70M | $81M | $101M | $98M | $37M | |
| Operating Income | $-8M | $-14M | $-2M | $-28M | $-35M | $8M | |
| Interest Expense | · | · | $2M | $2M | $7M | $698.0K | |
| Other Non-op | $-3M | $-934.0K | $-2M | $-2M | $-7M | $-698.0K | |
| Pretax Income | $-11M | $-15M | $-4M | $-30M | $-42M | $7M | |
| Income Tax | $60.0K | $61.0K | $221.0K | $63.0K | $2M | $2M | |
| Net Income | $-11M | $-15M | $-4M | $-30M | $-44M | $5M | |
| EPS (Basic) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.58 | |
| EPS (Diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 | |
| Shares (Basic) | 24,497,973 | 20,431,400 | 18,232,422 | 17,531,274 | 10,189,844 | 9,135,985 | |
| Shares (Diluted) | 24,497,973 | 20,431,400 | 18,232,422 | 17,531,274 | 10,189,844 | 10,836,122 | |
| EBITDA | $-8M | $-14M | $-2M | $-28M | $-35M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $20M | $27M | $32M | $49M | $8M | |
| Receivables | $30M | $10M | $15M | $28M | $23M | $24M | |
| Inventory | $10M | $14M | $10M | $14M | $10M | $1M | |
| Prepaid Expense | $3M | $3M | $4M | $3M | $2M | $2M | |
| Current Assets | $67M | $48M | $56M | $78M | $84M | $35M | |
| PP&E (Gross) | · | · | · | · | · | $11.0K | |
| Accum. Depreciation | · | · | · | · | · | $11.0K | |
| Intangibles | $28M | $32M | $20M | $27M | $13M | $15M | |
| Other Non-current Assets | · | · | $6.0K | $95.0K | $150.0K | $6.0K | |
| Total Assets | $95M | $80M | $77M | $105M | $97M | $52M | |
| Accounts Payable | $9M | $16M | $18M | $37M | $23M | $2M | |
| Accrued Liabilities | $28M | $17M | $20M | $19M | $23M | $21M | |
| Current Liabilities | $37M | $35M | $42M | $67M | $52M | $28M | |
| Capital Leases | $18.0K | $118.0K | $9.0K | $108.0K | · | $97.0K | |
| Total Liabilities | $63M | $60M | $56M | $88M | $55M | $42M | |
| Long-term Debt | $25M | $25M | $15M | $28M | · | · | |
| Total Debt | $25M | $25M | $15M | $20M | · | · | |
| Paid-in Capital | $130M | $107M | $93M | $85M | $81M | $5M | |
| Retained Earnings | $-98M | $-87M | $-72M | $-69M | $-39M | $5M | |
| Stockholders' Equity | $32M | $20M | $20M | $17M | $42M | $10M | |
| Liabilities + Equity | $95M | $80M | $77M | $105M | $97M | $52M | |
| Shares Outstanding | · | · | · | · | 11,316,344 | 3,151,333 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $0 | $5.0K | |
| Stock-based Comp | $6M | $6M | $3M | $4M | $2M | $153.0K | |
| Deferred Tax | · | · | · | · | $2M | $-335.0K | |
| Amort. of Intangibles | $4M | $3M | $4M | $4M | $2M | $1M | |
| Other Non-cash | · | · | · | · | $38M | · | |
| Operating Cash Flow | $-12M | $-9M | $5M | $-14M | $-2M | $5M | |
| CapEx | · | $15M | $5M | $20M | · | · | |
| Investing Cash Flow | · | $-15M | $-5M | $-20M | $-10M | $-1M | |
| Stock Issued | $16M | $8M | $4M | · | $33M | · | |
| Net Stock Activity | $16M | $8M | · | · | $33M | · | |
| Financing Cash Flow | $16M | $17M | $-5M | $16M | $53M | $-487.0K | |
| Net Change in Cash | $4M | $-7M | $-5M | $-17M | $41M | $3M | |
| Taxes Paid | $50.0K | $125.0K | $181.0K | $168.0K | $158.0K | $110.0K | |
| Free Cash Flow | · | $-24M | $240.0K | $-34M | · | · | |
| Levered FCF | · | · | $-2M | $-36M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | · | |
| Net Margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | · | |
| Pretax Margin | -18.4% | -26.0% | -4.6% | -40.1% | -67.1% | · | |
| EBITDA Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | · | |
| ROA | -13.1% | -18.7% | -4.2% | -29.3% | -59.0% | · | |
| ROE | -44.7% | -94.7% | -20.4% | -137.3% | -290.1% | · | |
| ROIC | -14.4% | -30.6% | -6.3% | -74.9% | -86.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.4 | 1.3 | 1.2 | 1.6 | · | |
| Quick Ratio | 1.4 | 0.9 | 1.0 | 0.9 | 1.4 | · | |
| Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · | · | |
| LT Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · | · | |
| Interest Coverage | · | · | -1.2 | -13.6 | -5.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.9 | 0.7 | 0.8 | · | |
| Inventory Turnover | 1.7 | 1.7 | 2.2 | 2.6 | 5.7 | · | |
| Receivables Turnover | 3.1 | 4.4 | 3.6 | 2.9 | 2.7 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $2.52 | $2.75 | · | $4.20 | $6.20 | · | |
| Cash Flow / Share | $-0.51 | $-0.45 | · | $-0.77 | $-0.21 | · | |
| EPS (TTM) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -29.1% | 7.5% | 16.7% | 41.8% | · | |
| Revenue CAGR 3Y | -5.7% | -3.8% | 21.1% | · | · | · | |
| Revenue CAGR 5Y | 6.8% | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $62M | $56M | $79M | $74M | $63M | · | |
| Net Income TTM | $-11M | $-15M | $-4M | $-30M | $-44M | · | |
| P/E | -16.4 | -5.4 | -27.4 | -1.1 | -1.2 | · | |
| Earnings Yield | -6.1% | -18.4% | -3.6% | -88.0% | -80.3% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $16M | $16M | $18M | $15M | $13M | $14M | $15M | $15M | $13M | $15M | $35M | $17M | $12M | $16M | $16M | |
| Cost of Revenue | $6M | $6M | · | · | $5M | $5M | $2M | $5M | $7M | $7M | $2M | $6M | $8M | $6M | $8M | $7M | |
| R&D Expense | $54.0K | · | $154.0K | $287.0K | $0 | $39.0K | $218.0K | $842.0K | $913.0K | $8M | $2M | $2M | $2M | $2M | $4M | $3M | |
| SG&A Expense | $11M | $10M | $10M | $12M | $12M | $11M | $10M | $11M | $10M | $8M | $10M | $9M | $12M | $13M | $14M | $16M | |
| Operating Expenses | $18M | $17M | $17M | $19M | $18M | $16M | $11M | $18M | $18M | $23M | $17M | $17M | $25M | $22M | $26M | $26M | |
| Operating Income | $456.0K | $-1M | $-443.0K | $-2M | $-3M | $-3M | $2M | $-3M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-10M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $548.0K | · | $268.0K | $756.0K | $650.0K | $617.0K | $559.0K | |
| Other Non-op | $-753.0K | $-738.0K | $-804.0K | $-786.0K | $-860.0K | $-749.0K | $-652.0K | $504.0K | $-434.0K | $-352.0K | $87.0K | $-361.0K | $-710.0K | $-575.0K | $-634.0K | $-578.0K | |
| Pretax Income | $-297.0K | $-2M | $-1M | $-2M | $-4M | $-4M | $2M | $-2M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-11M | $-10M | |
| Income Tax | $15.0K | · | $0 | $0 | $60.0K | · | · | · | · | · | $126.0K | $95.0K | · | · | $13.0K | $10.0K | |
| Net Income | $-312.0K | $-2M | $-1M | $-2M | $-4M | $-4M | $2M | $-2M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-11M | $-10M | |
| EPS (Basic) | $-0.01 | $-0.08 | $-0.04 | $-0.09 | $-0.16 | $-0.18 | $0.10 | $-0.12 | $-0.17 | $-0.53 | $-0.09 | $0.91 | $-0.46 | $-0.57 | $-0.61 | $-0.57 | |
| EPS (Diluted) | $-0.01 | $-0.08 | $-0.04 | $-0.09 | $-0.16 | $-0.18 | $0.10 | $-0.12 | $-0.17 | $-0.53 | $0.02 | $0.80 | $-0.46 | $-0.57 | $-0.61 | $-0.57 | |
| Shares (Basic) | 27,493,693 | 27,305,028 | · | 24,959,114 | 23,290,806 | 22,611,040 | · | 20,537,794 | 19,993,858 | 19,757,449 | · | 18,416,368 | 18,005,055 | 17,807,194 | · | 17,618,064 | |
| Shares (Diluted) | 27,493,693 | 27,305,028 | · | 24,959,114 | 23,290,806 | 22,611,040 | · | 20,537,794 | 19,993,858 | 19,757,449 | · | 21,034,758 | 18,005,055 | 17,807,194 | · | 17,618,064 | |
| EBITDA | $456.0K | $-1M | · | $-2M | $-3M | $-3M | · | $-3M | $-3M | $-10M | · | $17M | $-8M | $-10M | · | $-9M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $27M | $24M | $25M | $20M | $21M | $20M | $22M | $24M | $24M | $27M | $25M | $8M | $17M | $32M | $35M | |
| Receivables | $36M | $25M | $30M | $18M | $16M | $18M | $10M | $11M | $10M | $10M | $15M | $8M | $17M | $28M | $28M | $29M | |
| Inventory | $8M | $9M | $10M | $12M | $13M | $12M | $14M | $12M | $10M | $11M | $10M | $11M | $12M | $13M | $14M | $15M | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $1M | $2M | $3M | $4M | $924.0K | $2M | $2M | $3M | $942.0K | |
| Current Assets | $73M | $65M | $67M | $56M | $51M | $54M | $48M | $46M | $46M | $47M | $56M | $45M | $48M | $61M | $78M | $80M | |
| Intangibles | $26M | $26M | $28M | $29M | $30M | $31M | $32M | $18M | $19M | $19M | $20M | $21M | $22M | $26M | $27M | $28M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $88.0K | $95.0K | $103.0K | |
| Total Assets | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M | $65M | $67M | $77M | $66M | $70M | $96M | $105M | $108M | |
| Accounts Payable | $8M | $8M | $9M | $12M | $13M | $14M | $16M | $15M | $15M | $15M | $18M | $28M | $32M | $44M | $37M | $34M | |
| Accrued Liabilities | $32M | $26M | $28M | $21M | $23M | $23M | $17M | $16M | $16M | $20M | $20M | $16M | $23M | $17M | $19M | $18M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $46M | $38M | $37M | $40M | $40M | $40M | $35M | $33M | $34M | $39M | $42M | $49M | $68M | $77M | $67M | $61M | |
| Capital Leases | · | · | $18.0K | $44.0K | $69.0K | $94.0K | $118.0K | · | · | · | $9.0K | $34.0K | $59.0K | $84.0K | $108.0K | · | |
| Total Liabilities | $66M | $61M | $63M | $59M | $62M | $63M | $60M | $53M | $54M | $54M | $56M | $49M | $70M | $88M | $88M | $82M | |
| Long-term Debt | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $20M | $20M | $15M | $15M | $0 | $10M | $23M | $28M | · | |
| Total Debt | $25M | $25M | · | $25M | $25M | $25M | · | $20M | $20M | $15M | · | · | $10M | $20M | · | $20M | |
| Paid-in Capital | $133M | $132M | $130M | $123M | $114M | $113M | $107M | $99M | $97M | $96M | $93M | $88M | $87M | $86M | $85M | $84M | |
| Retained Earnings | $-101M | $-101M | $-98M | $-97M | $-95M | $-91M | $-87M | $-89M | $-86M | $-83M | $-72M | $-70M | $-87M | $-79M | $-69M | $-58M | |
| Stockholders' Equity | $32M | $31M | $32M | $26M | $19M | $22M | $20M | $11M | $11M | $13M | $20M | $17M | $5.0K | $7M | $17M | $26M | |
| Liabilities + Equity | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M | $65M | $67M | $77M | $66M | $70M | $96M | $105M | $108M |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $989.0K | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $529.0K | $558.0K | $873.0K | $646.0K | $1M | $1M | |
| Amort. of Intangibles | $969.0K | $1M | $1M | $1M | $1M | $1M | $982.0K | $814.0K | $814.0K | $814.0K | $815.0K | $814.0K | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-2M | $3M | $-6M | $-2M | $-942.0K | $-3M | $2M | $-1M | $-5M | $-5M | $-17M | $19M | $4M | $-956.0K | $-4M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $5M | $0 | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-5M | $0 | $0 | |
| Stock Issued | · | · | $5M | $7M | $0 | $4M | $6M | $194.0K | $0 | $1M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $4M | · | · | · | $1M | · | · | · | · | · | · | |
| Financing Cash Flow | $158.0K | $220.0K | $5M | $7M | $165.0K | $4M | $11M | $-294.0K | $5M | $2M | $19M | $-11M | $-13M | $52.0K | $948.0K | $4M | |
| Net Change in Cash | $-2M | $3M | $-858.0K | $5M | $-777.0K | $765.0K | $-2M | $-1M | $-145.0K | $-3M | $3M | $8M | $-9M | $-6M | $-3M | $-3M | |
| Taxes Paid | · | · | $1.0K | $0 | · | · | $21.0K | $1.0K | · | · | $96.0K | $0 | $78.0K | $7.0K | $149.0K | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-6M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.5% | -9.3% | · | -8.7% | -19.2% | -25.3% | · | -19.8% | -19.7% | -77.4% | · | 49.9% | -44.6% | -78.3% | · | -58.9% | |
| Net Margin | -1.7% | -14.0% | · | -13.1% | -25.3% | -31.0% | · | -16.3% | -22.6% | -80.1% | · | 48.6% | -48.7% | -83.0% | · | -62.5% | |
| Pretax Margin | -1.6% | -14.0% | · | -13.1% | -24.9% | -31.0% | · | -16.3% | -22.6% | -80.1% | · | 48.9% | -48.7% | -83.0% | · | -62.5% | |
| EBITDA Margin | 2.5% | -9.3% | · | -8.7% | -19.2% | -25.3% | · | -19.8% | -19.7% | -77.4% | · | 49.9% | -44.6% | -78.3% | · | -58.9% | |
| ROA | -0.35% | -2.5% | · | -3.1% | -5.2% | -5.4% | · | -3.7% | -5.0% | -12.9% | · | 19.3% | -9.1% | -9.3% | · | -10.2% | |
| ROE | -1.2% | -8.5% | · | -12.6% | -24.9% | -23.6% | · | -16.9% | -59.5% | -102.2% | · | 77.1% | -48.1% | -41.4% | · | -139.3% | |
| ROIC | 0.83% | · | · | · | -6.6% | · | · | · | · | · | · | 98.7% | · | · | · | -20.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | · | 1.4 | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | |
| Quick Ratio | 1.4 | 1.4 | · | 1.1 | 0.9 | 1.0 | · | 1.0 | 1.0 | 0.9 | · | 0.7 | 0.4 | 0.6 | · | 1.0 | |
| Debt / Equity | 0.8 | 0.8 | · | 1.0 | 1.3 | 1.2 | · | 1.8 | 1.7 | 1.1 | · | · | 1988.4 | 2.6 | · | 0.8 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.8 | 1.1 | 1.1 | · | 1.8 | 1.7 | 1.1 | · | · | · | 1.3 | · | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.4 | · | 64.3 | -10.1 | -14.7 | · | -17.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.6 | 0.6 | · | · | · | · | · | 0.5 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.4 | · | 0.5 | |
| Receivables Turnover | 0.7 | 0.7 | · | 1.2 | 1.1 | 0.9 | · | 1.6 | 1.1 | 0.7 | · | 1.9 | 0.8 | 0.4 | · | 0.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.67 | $0.58 | · | $0.71 | $0.64 | $0.58 | · | $0.71 | $0.74 | $0.66 | · | $1.64 | $0.95 | $0.69 | · | $0.91 | |
| Cash Flow / Share | · | $0.11 | · | · | · | $-0.13 | · | · | · | $-0.25 | · | · | · | $-0.05 | · | · | |
| EPS (TTM) | $-0.22 | $-0.37 | · | $-0.33 | $-0.36 | $-0.37 | · | $-0.80 | $0.12 | $-0.17 | · | $-0.84 | $-2.21 | $-2.18 | · | $-2.96 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $68M | $65M | · | $59M | $56M | $56M | · | $58M | $78M | $80M | · | $80M | $61M | $63M | · | $75M | |
| Net Income TTM | $-6M | $-10M | · | $-9M | $-9M | $-8M | · | $-18M | $843.0K | $-4M | · | $-12M | $-39M | $-38M | · | $-41M | |
| P/E | -32.2 | -12.7 | · | -21.6 | -19.9 | -15.9 | · | -7.1 | 47.0 | -21.6 | · | -3.3 | -0.7 | -0.7 | · | -0.8 | |
| Earnings Yield | -3.1% | -7.9% | · | -4.6% | -5.0% | -6.3% | · | -14.2% | 2.1% | -4.6% | · | -30.7% | -139.0% | -138.8% | · | -120.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $62M | $56M | $79M | $74M | $63M |
| Operating Margin % | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% |
| Net Income | $-11M | $-15M | $-4M | $-30M | $-44M |
| Diluted EPS | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · |
| Current Ratio | 1.8 | 1.4 | 1.3 | 1.2 | 1.6 |
| Quick Ratio | 1.4 | 0.9 | 1.0 | 0.9 | 1.4 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-24M | $240.0K | $-34M | · |
Institutional owners (13F) 75 filers · $72.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
75
Value held
$72.0M
New positions
25
Exited positions
23
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 25 (+10 vs prior Q) | 23 (+8 vs prior Q) | 17 (-14 vs prior Q) | 23 (+6 vs prior Q) | -4.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $11,398,800 | 1,610,000 | 15.83% | Shares |
| WASATCH ADVISORS LP | $10,005,505 | 2,133,370 | 13.90% | Shares |
| VANGUARD GROUP INC | $5,891,574 | 764,147 | 8.18% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,780,310 | 675,185 | 6.64% | Shares |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $3,794,880 | 536,000 | 5.27% | Shares |
| Pale Fire Capital SE | $3,742,375 | 528,584 | 5.20% | Shares |
| Opaleye Management Inc. | $2,478,000 | 350,000 | 3.44% | Shares |
| Summit Financial, LLC | $2,454,976 | 346,748 | 3.41% | Shares |
| JANE STREET GROUP, LLC | $2,265,749 | 320,021 | 3.15% | Shares |
| Diametric Capital, LP | $2,093,294 | 295,663 | 2.91% | Shares |
| Ikarian Capital, LLC | $1,780,168 | 251,436 | 2.47% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,626,276 | 229,700 | 2.26% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,530,115 | 216,004 | 2.13% | Shares |
| AMERICAN FINANCIAL GROUP INC | $1,274,400 | 180,000 | 1.77% | Shares |
| Trexquant Investment LP | $1,213,073 | 171,338 | 1.69% | Shares |
| MARSHALL WACE, LLP | $990,087 | 139,843 | 1.38% | Shares |
| J. Goldman & Co LP | $974,095 | 137,584 | 1.35% | Shares |
| Sheets Smith Investment Management | $946,276 | 132,904 | 1.31% | Shares |
| MILLENNIUM MANAGEMENT LLC | $778,913 | 110,016 | 1.08% | Shares |
| BlackRock, Inc. | $714,945 | 100,981 | 0.99% | Shares |
| XTX Topco Ltd | $714,535 | 100,923 | 0.99% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $670,681 | 94,729 | 0.93% | Shares |
| GOLDMAN SACHS GROUP INC | $639,282 | 90,294 | 0.89% | Shares |
| UBS Group AG | $591,279 | 83,514 | 0.82% | Shares |
| CITADEL ADVISORS LLC | $581,615 | 82,149 | 0.81% | Shares |
| PVG ASSET MANAGEMENT CORP | $563,377 | 79,573 | 0.78% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $477,489 | 67,442 | 0.66% | Shares |
| STATE STREET CORP | $467,124 | 65,978 | 0.65% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $466,041 | 65,825 | 0.65% | Shares |
| Walleye Capital LLC | $463,471 | 65,462 | 0.64% | Shares |
| Geneos Wealth Management Inc. | $448,022 | 63,280 | 0.62% | Shares |
| Frec Markets, Inc. | $357,540 | 50,500 | 0.50% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $335,670 | 47,411 | 0.47% | Shares |
| Squarepoint Ops LLC | $321,467 | 45,405 | 0.45% | Shares |
| MORGAN STANLEY | $297,530 | 42,024 | 0.41% | Shares |
| BANK OF AMERICA CORP /DE/ | $296,701 | 41,907 | 0.41% | Shares |
| Integrated Wealth Concepts LLC | $280,212 | 39,578 | 0.39% | Shares |
| ADAR1 Capital Management, LLC | $279,780 | 39,517 | 0.39% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $254,200 | 35,904 | 0.35% | Shares |
| NORTHERN TRUST CORP | $252,444 | 35,656 | 0.35% | Shares |
| Aster Capital Management (DIFC) Ltd | $217,498 | 30,720 | 0.30% | Shares |
| SALEM INVESTMENT COUNSELORS INC | $206,736 | 29,200 | 0.29% | Shares |
| Quadrature Capital Ltd | $204,194 | 28,841 | 0.28% | Shares |
| JANE STREET GROUP, LLC | $201,072 | 28,400 | 0.28% | Call option |
| AQR CAPITAL MANAGEMENT LLC | $176,129 | 24,877 | 0.24% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $155,087 | 21,905 | 0.22% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $141,607 | 20,001 | 0.20% | Shares |
| Gladstone Institutional Advisory LLC | $141,600 | 20,000 | 0.20% | Shares |
| Brevan Howard Capital Management LP | $133,508 | 18,857 | 0.19% | Shares |
| Invesco Ltd. | $118,087 | 16,679 | 0.16% | Shares |
Company insiders 11 insiders · 4 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Claude Maraoui | President & CEO | April 22, 2026 A | 2,435,990 | 0 | 0 | $0 |
| Joseph Benesch | CFO | April 22, 2026 A | 261,371 | 0 | 0 | $0 |
| Ernest Robert De Paolantonio | As of the date of the original Form 4 filed on October 6, 2022, the Reporting Person was the Chief Financial Officer of the Issu | Oct. 4, 2022 S | 259,907 | 0 | 0 | $0 |
| Ramsey Alloush | Chief Operating Officer | April 22, 2026 A | 598,543 | 0 | 0 | $0 |
| Justin Adam Smith | Director | July 1, 2026 A | 231,618 | 0 | 0 | $0 |
| Miranda Jayne Toledano | Director | July 1, 2026 A | 168,618 | 0 | 0 | $0 |
| Neil Herskowitz | Director | July 1, 2026 A | 168,618 | 0 | 0 | $0 |
| Michael Cooper Pearce | Director | June 25, 2026 A | 67,173 | 0 | 0 | $0 |
| Lindsay A. Rosenwald, M.D. | Director | June 25, 2026 A | 221,146 | 0 | 0 | $0 |
| Jeffrey Paley | Director | Nov. 8, 2023 S | 114,217 | 0 | 0 | $0 |
| Fortress Biotech, Inc. | 10% owner | May 12, 2023 J | 3,860,467 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
DERM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$13.50
+104.2%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-09-29Mean target $13.75 +108.0%
← Below all targets
Current price $6.61
Low$13.00
Mean$13.75
High$15.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026